P-01 Hereditary angioedema with normal C1-INH and PLG muta-tion treated with tranexamic acid: Beware of the risk of thrombosis Alexis Bocquet, David Launay, Isabelle Boccon-Gibod, Aurlie Du-Thanh, Delphiine Gobert, Sbastien Sanges, Laurence Bouillet Launay &Sanges University of Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, F-59000, INSERM, and the Department of Internal Medicine and Clinical Immunology, CHU Lille, National Reference Center for Angioedema (CREAK), Lille, France Allergy, Asthma & Clinical Immunology 2025, 21(Suppl 2) :P-01 Introduction: The anti-fibrinolytic, tranexamic acid (TA) can be proposed as a long term prophylaxis for hereditary angioedema (HAE), and seems to be specifically efficient for HAE with plasminogen gene mutation (HAE-PLG), a subset of HAE with normal C1-INH (HAE-nC1-INH)
Esto est bajo mi control
Ultimately, GLP-1RAs enhance insulin excretion, leading to the inhibition of glucagon production by pancreatic -cells when blood sugar levels are high as well as a decrease of pancreatic -cell apoptosis and an increase in their proliferation
Mechanistically, the metabolic benefits of Godex depend on enhanced activity of CrAT, which modulates mitochondrial acetyl-CoA metabolism and thereby improves insulin sensitivity and hepatic lipid homeostasis (33)
